12:00 AM
Feb 11, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BVdU: Phase II started

SciClone began a double-blind, placebo-controlled, international Phase II trial in 153 patients to evaluate 6 cycles of gemcitabine with or without RP101 for 3 weeks followed by 1 week of...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >